Carregant...
Anti-CTLA-4 therapy-associated granuloma annulare in chronic myelomonocytic leukemia
Immune checkpoint inhibitor (ICI) therapies activate the immune system to unmask cancer cells that the body might otherwise not detect. These cancer therapies alter the immune system at different “checkpoint” proteins such as PD-1, PD-L1, or CTLA-4 to better target tumor cells, but also have the pot...
Guardat en:
| Publicat a: | Proc (Bayl Univ Med Cent) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7785184/ https://ncbi.nlm.nih.gov/pubmed/33456170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08998280.2020.1818165 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|